# Hetero Labs Ltd. - Unit IX - Inspection Records

Source: https://www.globalkeysolutions.net/companies/hetero-labs-ltd-unit-ix/b44e59b6-5413-4ef1-83a3-411f3684bdc3

> Inspection records and compliance data for Hetero Labs Ltd. - Unit IX in Visakhapatnam, None. Access full analysis and detailed observations.

---

## Details

- Name: Hetero Labs Ltd. - Unit IX
- FEI Number: 3009093782
- City: Visakhapatnam
- State: None
- Country Name: India
- Address Line 1: Unit Ix, Plot No. 2, Hetero Infrastructure Sez, Narasapuram Village, Nakkapalli Mandal
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [483 - Hetero Labs Ltd. - Unit IX - 2025-09-26](https://www.globalkeysolutions.net/records/483/hetero-labs-ltd-unit-ix/a9538a13-016c-40c8-a7df-68910eede01a) — source: FDA, date: September 26, 2025
- [483 - Hetero Labs Ltd. - Unit IX - 2025-09-26](https://www.globalkeysolutions.net/records/483/hetero-labs-ltd-unit-ix/1122e056-7a9c-4b0e-aaa0-2b2217353a70) — source: FDA, date: September 26, 2025
- [FDA Inspection 1297806 - Hetero Labs Ltd. - Unit IX - 2025-09-26](https://www.globalkeysolutions.net/records/fda_inspections/hetero-labs-ltd-unit-ix/dcbb9a04-e3fa-4537-8c39-3322e3fc7a5a) — source: FDA, date: September 26, 2025
- [483 - Hetero Labs Ltd. - Unit IX - 2022-11-08](https://www.globalkeysolutions.net/records/483/hetero-labs-ltd-unit-ix/00df0fd4-9f6a-45ea-9d14-e206d2fde28f) — source: FDA, date: November 8, 2022
- [FDA Inspection 1193038 - Hetero Labs Ltd. - Unit IX - 2022-11-08](https://www.globalkeysolutions.net/records/fda_inspections/hetero-labs-ltd-unit-ix/50ef66ac-305e-4985-8131-9dac2f40226a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 8, 2022
- [483 - Hetero Labs Ltd. - Unit IX - 2019-05-14](https://www.globalkeysolutions.net/records/483/hetero-labs-ltd-unit-ix/7ae33c50-5478-4036-847c-57491e2d9696) — source: FDA, date: May 14, 2019
- [483 - Hetero Labs Ltd. - Unit IX - 2019-05-14](https://www.globalkeysolutions.net/records/483/hetero-labs-ltd-unit-ix/7bc98be1-a256-46dd-a3b6-45f39f9de716) — source: FDA, date: May 14, 2019
- [FDA Inspection 1089874 - Hetero Labs Ltd. - Unit IX - 2019-05-14](https://www.globalkeysolutions.net/records/fda_inspections/hetero-labs-ltd-unit-ix/4b35b2a7-73f0-49bb-8704-815c31a25409) — classification: Official Action Indicated (OAI), source: FDA, date: May 14, 2019
- [FDA Inspection 1024034 - Hetero Labs Ltd. - Unit IX - 2017-08-18](https://www.globalkeysolutions.net/records/fda_inspections/hetero-labs-ltd-unit-ix/a432d02c-69aa-4d9f-a360-63a3e29d6d14) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 18, 2017
- [FDA Inspection 898993 - Hetero Labs Ltd. - Unit IX - 2014-09-29](https://www.globalkeysolutions.net/records/fda_inspections/hetero-labs-ltd-unit-ix/25ccb6aa-7abc-42b6-aafa-653e6cea7e05) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2014
- [FDA Inspection 779428 - Hetero Labs Ltd. - Unit IX - 2011-12-15](https://www.globalkeysolutions.net/records/fda_inspections/hetero-labs-ltd-unit-ix/1d550e19-3933-49c1-9045-61e40afd75fc) — classification: No Action Indicated (NAI), source: FDA, date: December 15, 2011

## Related Companies

- [Zhejiang Tianyu Pharmaceutical Co. Ltd.](https://www.globalkeysolutions.net/companies/zhejiang-tianyu-pharmaceutical-co-ltd/b7ecf3cd-082c-48b5-94e1-8adeba7ce167)
- [Cdymax (India) Pharma Private Limited](https://www.globalkeysolutions.net/companies/cdymax-india-pharma-private-limited/51bc8d84-9900-43c0-8e1c-9d2bd08b0ac4)
- [Centrient Pharmaceuticals India Private Limited](https://www.globalkeysolutions.net/companies/centrient-pharmaceuticals-india-private-limited/cb4cf503-2578-4e8f-b226-d736e975468e)
- [Tokyo Chemical Industry Co Ltd](https://www.globalkeysolutions.net/companies/tokyo-chemical-industry-co-ltd/777f1c4a-29f8-48cc-9a51-dc89b896f327)
- [Les Produits Chimiques B.G.R., Inc.](https://www.globalkeysolutions.net/companies/les-produits-chimiques-bgr-inc/348f9540-7743-4466-b340-676434a19914)
- [Symbiotec Pharmalab Limited](https://www.globalkeysolutions.net/companies/symbiotec-pharmalab-limited/70a966a5-ef02-46b0-8e2a-8a953f473496)
- [Alchymars ICM SM Private Limited](https://www.globalkeysolutions.net/companies/alchymars-icm-sm-private-limited/e545dac9-72db-4c33-8111-32531c53be5d)
- [Jiangsu NHWA Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/jiangsu-nhwa-pharmaceutical-co-ltd/7b3402dc-1e72-471c-ba50-33f225ac6625)
- [Hubei JXBio Pharmaceutical Co., Ltd](https://www.globalkeysolutions.net/companies/hubei-jxbio-pharmaceutical-co-ltd/0cb70a5f-908f-45e1-bf50-87d4e83281b5)
- [Flamma USA LLC](https://www.globalkeysolutions.net/companies/flamma-usa-llc/e8b09d1a-f37b-4e4b-bff0-dc0533ac62f3)

## Related Officers

- [Consumer Safety Officer](https://www.globalkeysolutions.net/people/rajiv-r-srivastava/05b42bfd-0cf4-42ce-89e1-b81bf36eaa17)
- [FDA Alumnus, Principal at ESCODA Consulting Group, and Scientific Advisory Board Member at AiZen Algo](https://www.globalkeysolutions.net/people/concepcion-cruz/831264a6-1a6b-47f1-b0bf-f3091d3b2f1c)
- [Lata C. Mathew](https://www.globalkeysolutions.net/people/lata-c-mathew/0610a0ef-dcc5-43e7-ab74-2ac54d758beb)
- [Arsen Karapetyan](https://www.globalkeysolutions.net/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)